Mechanistic study of the uptake/permeation of cell-penetrating peptides across a caco-2 monolayer and their stimulatory effect on epithelial insulin transport

J Pharm Sci. 2013 Nov;102(11):3998-4008. doi: 10.1002/jps.23708. Epub 2013 Aug 20.

Abstract

Our recent studies have demonstrated the potential of cell-penetrating peptides (CPPs) to significantly stimulate the intestinal absorption of therapeutic peptides and proteins. This study examined the mechanisms underlying the intestinal epithelial uptake and permeation of CPPs and their contribution to the enhanced absorption of insulin. Fluorescein-tagged octaarginine (R8) and penetratin were used as the promising CPPs, and in vitro uptake and permeation assays were conducted using Caco-2 cell monolayer. The assay conducted under low temperature conditions revealed that energy-dependent pathways are not involved in d-form arginines (d-R8) uptake or its stimulatory effect on insulin uptake. The Km value (3.82 μM), calculated from the dose dependence of d-R8 uptake, suggested that a part of the d-R8 uptake was saturated at the functional concentration (60 μM d-R8). An analysis based on the binding parameters of insulin and d-R8 also showed an increase in the uptake clearance of the insulin/d-R8 complex, even at a saturated concentration of d-R8, implying that this complex is taken up by Caco-2 cells via pathways that differ from those that take up unbound d-R8. Thus, this study suggests that CPPs such as oligoarginines stimulate the intestinal epithelial transport of peptide and protein drugs via energy-independent unsaturable internalization.

Keywords: Caco-2 cells; cell-penetrating peptides (CPPs); epithelial delivery/permeability; epithelial permeation; insulin; intestinal absorption; oligoarginine; oral drug delivery; penetratin; transcellular transport.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Caco-2 Cells
  • Carrier Proteins / metabolism*
  • Cell-Penetrating Peptides / metabolism*
  • Humans
  • Hypoglycemic Agents / administration & dosage*
  • Hypoglycemic Agents / pharmacokinetics
  • Insulin / administration & dosage*
  • Insulin / pharmacokinetics
  • Oligopeptides / metabolism*
  • Permeability
  • Pharmaceutical Vehicles / metabolism*

Substances

  • Carrier Proteins
  • Cell-Penetrating Peptides
  • Hypoglycemic Agents
  • Insulin
  • Oligopeptides
  • Pharmaceutical Vehicles
  • octaarginine
  • penetratin